Abstract
(1) Viral-based approaches to non-invasive whole-brain cargo delivery: Genetically-encoded tools that can be used to visualize, monitor, and modulate mammalian neurons are revolutionizing neuroscience. These tools are particularly powerful in rodents and invertebrate models where intersectional transgenic strategies are available to restrict their expression to defined cell populations. However, use of genetic tools in non-transgenic animals is often hindered by the lack of vectors capable of safe, efficient, and specific delivery to the desired cellular targets. To begin to address these challenges, we have developed an in vivo Cre-based selection platform (CREATE) for identifying adeno-associated viruses (AAVs) that more efficiently transduce genetically defined cell populations. Our platform’s novelty and power arises from the additional selective pressure imparted by a recovery step that amplifies only those capsid variants that have functionally transduced a genetically-defined, Cre-expressing target cell population. The Cre-dependent capsid recovery works within heterogeneous tissue samples without the need for additional steps such as selective capsid recovery approaches that require cell sorting or secondary adenovirus infection. As a first test of the CREATE platform, we selected for viruses that transduced the brain after intravascular delivery and found a novel vector, AAV-PHP.B, that is 40- to 90-fold more efficient at transducing the brain than the current standard, AAV9. AAV-PHP.B transduces most neuronal types and glia across the brain. We also demonstrate here how whole-body tissue clearing can facilitate transduction maps of systemically delivered genes. Since CNS disorders are notoriously challenging due to the restrictive nature of the blood brain barrier our discovery that recombinant vectors can be engineered to overcome this barrier is enabling for the whole field. With the exciting advances in gene editing via the CRISPR-Cas, RNA interference and gene replacement strategies, the availability of potent gene delivery methods provided by vectors such as our reported AAV-PHP.B is key to advancing the field of genome engineering.
© 2017 Optical Society of America
PDF Article | Presentation VideoMore Like This
Chen Zhang, Cheng Yan, Miao Ren, Anan Li, Tingwei Quan, Hui Gong, and Jing Yuan
W3A.42 International Conference on Photonics and Imaging in Biology and Medicine (PIBM) 2017
Zhiguang Wang, Shangbin Chen, Hui Gong, Qingming Luo, and Anan Li
W3A.73 International Conference on Photonics and Imaging in Biology and Medicine (PIBM) 2017
Shunichi Sato, Takahiro Ando, Yasushi Satoh, Hiroshi Nawashiro, and Minoru Obara
TuJ3_2 Conference on Lasers and Electro-Optics/Pacific Rim (CLEO/PR) 2013